| Id |
Subject |
Object |
Predicate |
Lexical cue |
| 16822847-2#90#94#gene2064 |
474-478 |
gene2064 |
denotes |
HER2 |
| 16822847-2#189#202#diseaseC0006142 |
573-586 |
diseaseC0006142 |
denotes |
breast cancer |
| 16822847-2#189#202#diseaseC0678222 |
573-586 |
diseaseC0678222 |
denotes |
breast cancer |
| 16822847-0#0#5#gene2264 |
792-797 |
gene2264 |
denotes |
FGFR4 |
| 16822847-0#81#94#diseaseC0006142 |
1637-1805 |
diseaseC0006142 |
denotes |
bout half as much benefit from adjuvant systemic therapy as wild-type carriers.
CONCLUSION: According to this study, FGFR4 Arg388 genotype is a marker for breast cancer |
| 16822847-0#81#94#diseaseC0678222 |
1637-1805 |
diseaseC0678222 |
denotes |
bout half as much benefit from adjuvant systemic therapy as wild-type carriers.
CONCLUSION: According to this study, FGFR4 Arg388 genotype is a marker for breast cancer |
| 0#5#gene226481#94#diseaseC0006142 |
16822847-0#0#5#gene2264 |
16822847-0#81#94#diseaseC0006142 |
associated_with |
FGFR4,"bout half as much benefit from adjuvant systemic therapy as wild-type carriers.
CONCLUSION: According to this study, FGFR4 Arg388 genotype is a marker for breast cancer" |
| 0#5#gene226481#94#diseaseC0678222 |
16822847-0#0#5#gene2264 |
16822847-0#81#94#diseaseC0678222 |
associated_with |
FGFR4,"bout half as much benefit from adjuvant systemic therapy as wild-type carriers.
CONCLUSION: According to this study, FGFR4 Arg388 genotype is a marker for breast cancer" |
| 90#94#gene2064189#202#diseaseC0006142 |
16822847-2#90#94#gene2064 |
16822847-2#189#202#diseaseC0006142 |
associated_with |
HER2,breast cancer |
| 90#94#gene2064189#202#diseaseC0678222 |
16822847-2#90#94#gene2064 |
16822847-2#189#202#diseaseC0678222 |
associated_with |
HER2,breast cancer |
